Nothing alarming: on China’s HMPV cases
The HinduFive years after the SARS-CoV-2 virus overwhelmed hospitals in Wuhan, China, acute respiratory diseases caused by viruses including the human metapneumovirus in children and the elderly, and influenza and respiratory syncytial virus, are increasing in the country, especially in its northern provinces. Globally, 3%-10% of hospital admissions and 1% of acute lower respiratory infection-related deaths in children under age five in 2018 are attributed to HMPV, as per a 2021 paper. Detection of a large number of HMPV cases among children aged less than 14 years in China is a reflection of the heightened surveillance and testing for the virus. When testing for HMPV in patients with acute respiratory disease should be routine, as the virus has been in circulation for years globally, including India, and fatality is 1% in young children, India is only now expanding the number of laboratories testing for HMPV beyond the Indian Council of Medical Research network due to the spike in HMPV cases in China.